certolizumab pegol

Autoimmune drug pipeline: What health execs should watchNew drugs for RA, psoriasis, type 1 diabetes and Crohn’s disease—some recently approved and others coming down the pipeline—could have an impact on the industry.
FDA approves Cimzia for psoriatic arthritisCimzia (certolizumab pegol, UCB) has been approved by the Food and Drug Administration for the treatment of psoriatic arthritis in adult patients.